NCT00427401View on ClinicalTrials.gov

A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

June 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

PF-00915275

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY